Rights and permissions
About this article
Cite this article
Epoetin alfa plus lenograstim costly, no QOL benefit in anaemia. Pharmacoecon. Outcomes News 459, 14 (2004). https://doi.org/10.2165/00151234-200404590-00038
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404590-00038